Pagenax Brolucizumab 120 mg/ml Injection
Pagenax Brolucizumab 120 mg/ml Injection is an anti-VEGF medication used for the treatment of neovascular (wet) age-related macular degeneration (AMD) and other retinal disorders. It contains Brolucizumab, a monoclonal antibody fragment that works by blocking vascular endothelial growth factor (VEGF), reducing abnormal blood vessel growth and fluid leakage in the retina.
This helps improve and stabilize vision in patients suffering from retinal diseases. Pagenax is administered as an intravitreal injection by an eye specialist in a clinical setting.
Storage: Store at 2°C to 8°C, protect from light, and do not freeze.
Buy Pagenax Brolucizumab 120 mg/ml Injection | Brolucizumab Exporter from India
Pagenax Brolucizumab 120 mg/ml Injection is a highly effective treatment for wet age-related macular degeneration (AMD) and other retinal conditions. By inhibiting VEGF, it helps prevent abnormal blood vessel growth and fluid accumulation in the retina, supporting better vision outcomes.
We are a reliable pharmaceutical exporter from India, supplying Pagenax Brolucizumab Injection to hospitals, eye clinics, distributors, and pharmacies with safe packaging and fast global delivery.
We export high-quality specialty medicines to Australia, Europe, United Kingdom, United States, Chile, Peru, Ethiopia, Romania, China, Japan, Russia, Ukraine, Dubai, United Arab Emirates, South Korea, Africa, Thailand, Vietnam, Middle East, and Southeast Asian countries.
Why Choose Our Export Services
-
Trusted global pharmaceutical exporter from India
-
Supply of WHO-GMP certified medicines
-
Competitive wholesale pricing
-
Temperature-controlled shipping
-
Fast international delivery
